gentamicin vs Bordrless

gentamicin (GENTA) and Bordrless (BORDR) compared side by side. Over the past 30 days, GENTA is ahead by 3.6 percentage points (GENTA -96.1% against BORDR -99.7%). Their daily returns move barely in opposite directions (correlation -0.29 across 25 shared trading days). BORDR has been the more volatile of the two, at 862% annualised against GENTA's 332%.

Correlation
-0.29
Ahead over 30 days
GENTA
gentamicinGENTA

$1.602e-6

24h
-0.55%
Market cap
—
Volume 24h
$0
Volatility (ann.)
332%
BordrlessBORDR

$1.230e-5

24h
-10.86%
Market cap
$12,298
Volume 24h
$948,065
Volatility (ann.)
862%
GENTA 0.0%Share of the two combined market caps100.0% BORDR

Performance

GENTABORDR

  1. 7 days-26.75%-34.96%GENTA
  2. 30 days-96.11%-99.67%GENTA

Correlation

-0.29over 25 shared trading days

−1 opposite0 unrelated+1 in step
7d: insufficient data30d: -0.2990d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

MetricGENTABORDR
Max drawdown (400d)-96.1%-99.8%
Risk-adjusted return (90d)-0.29-0.11

Relative strength over 90 days: GENTA outperformed BORDR by 1984.8% — measured on the GENTA/BORDR ratio, so it holds regardless of market direction.